MARKET

LYRA

LYRA

Lyra Therapeutics, Inc.
OTCPK
0.685
-0.005
-0.72%
Closed 15:07 05/01 EDT
OPEN
0.685
PREV CLOSE
0.690
HIGH
0.750
LOW
0.685
VOLUME
4.92K
TURNOVER
3.37K
52 WEEK HIGH
37.50
52 WEEK LOW
0.310
MARKET CAP
1.22M
P/E (TTM)
-0.0368
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LYRA last week (0420-0424)?
Weekly Report · 4d ago
Weekly Report: what happened at LYRA last week (0413-0417)?
Weekly Report · 04/20 10:33
Lyra Therapeutics Ends Major Office Sublease Agreement
TipRanks · 04/17 13:18
Lyra Therapeutics announces intention to file Form 25 for delisting from Nasdaq
TipRanks · 04/17 12:16
Weekly Report: what happened at LYRA last week (0406-0410)?
Weekly Report · 04/13 10:38
Lyra Therapeutics Streamlines Operations with Major Lease Terminations
TipRanks · 04/10 13:17
Weekly Report: what happened at LYRA last week (0330-0403)?
Weekly Report · 04/06 10:38
Weekly Report: what happened at LYRA last week (0323-0327)?
Weekly Report · 03/30 10:39
More
About LYRA
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of therapies for the localized treatment of patients with chronic rhinosinusitis (CRS). The Company is developing therapies for CRS, a prevalent inflammatory disease of the paranasal sinuses that leads to debilitating symptoms and significant morbidities. LYR-210, the Company’s lead product, is a bioabsorbable nasal implant designed to be administered in a simple, in-office procedure and is intended to deliver six months of continuous anti-inflammatory drug therapy to the sinonasal passages for the treatment of CRS with a single administration. LYR-210, being evaluated in the ENLIGHTEN Phase III clinical program, is intended for patients with and without nasal polyps. The drug embedded within LYR-210 is mometasone furoate (MF).

Webull offers Lyra Therapeutics Inc stock information, including OTCPK: LYRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LYRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LYRA stock methods without spending real money on the virtual paper trading platform.